A biopsia hepatica removes a small piece of hígado so it can be examined under a microscope. A liver biopsy is done for one of two main reasons. The first is to find the cause of a liver problem, such as abnormal liver blood tests, and to measure how much damage it has caused. The second is to find out what a spot or lump seen on a scan is.
This article explains how a liver biopsy sample is taken and handled in the laboratory. It also explains the grade and stage on your report and what each common result means for you. It covers the whole report, not just one diagnosis, and links to our guides for each condition.
¿Por qué se hace una biopsia de hígado?
A liver biopsy is usually done when blood tests and scans cannot fully answer a question about the liver. Common reasons include:
- Abnormal liver blood tests. When liver enzymes stay high and the cause is not clear, a biopsy can show what kind of injury is happening. Our guide to understanding your liver panel explains these blood tests.
- A known liver disease. In conditions such as fatty liver disease or autoimmune hepatitis, a biopsy measures how much inflammation and scarring are present. This helps your care team plan treatment.
- Checking the response to treatment. A repeat biopsy can show whether inflammation or scarring has improved.
- A liver transplant. A biopsy can check how a transplanted liver is working and look for rejection.
- A spot or lump on a scan. A biopsy aimed at the spot shows whether it is noncancerous, a cancer that started in the liver, or a cancer that spread from somewhere else.
How is the liver biopsy sample collected?
Most liver biopsy samples are thin cores of tissue, about 1 to 2 centimeters long and as wide as the lead in a pencil. The sample can be collected in several ways:
- Through the skin. A doctor passes a thin needle through the skin of the right side of the abdomen or lower chest, usually guided by ultrasound. This is the most common method.
- Through a vein in the neck (transjugular). A thin tube is passed through a vein in the neck down to the liver. This approach is used when there is a higher risk of bleeding or fluid around the liver.
- Through an endoscope. A needle is passed through a thin, flexible scope placed in the stomach, guided by ultrasound.
- Durante la cirugía. A surgeon may remove a small wedge of liver, or take a needle sample, during an operation done for another reason.
What happens to the liver biopsy in the laboratory?
In the laboratory, the liver biopsy is preserved, cut into very thin slices, and placed on glass slides. Every sample is stained with a standard pink-and-purple stain that shows the cells and their structure. A patólogo then examines the slides under the microscope.
For most liver biopsies done to investigate liver disease, the pathologist also orders special stains. Each one highlights something the standard stain cannot show clearly. Your report may mention:
- Trichrome. This stain colors scar tissue (fibrosis) blue. It is used to measure the stage of liver disease.
- Reticulina. This stain outlines the fine framework that holds liver cells in place. It helps show whether the liver’s normal structure has been damaged.
- Hierro. This stain shows iron as blue granules. A normal liver has little or no stainable iron, so a positive result can point to iron overload.
- PAS-D. This stain can show small round clumps of a protein called alpha-1 antitrypsin, which build up in an inherited condition called alpha-1 antitrypsin deficiency.
- Cobre. This stain looks for extra copper, which builds up in a rare inherited condition called Wilson disease.
When the biopsy is taken from a spot or lump, the pathologist may use inmunohistoquímica instead. These stains help show what type of cell the growth is made of and where it started.
Is the liver biopsy sample big enough?
A liver biopsy samples only a tiny part of the liver, so its size matters. Pathologists judge a sample by its length and by how many portal tracts it contains. Portal tracts are small bundles of a bile duct and two blood vessels spread evenly through the liver. Many experts consider a sample about 2 centimeters long, or one with about 10 or more portal tracts, large enough for a reliable stage.
A smaller or broken-up sample can still provide an answer, but the report may note that it is limited. In that case, the true amount of scarring may be higher or lower than the sample shows. Your doctor will decide whether the result is enough or whether you need a repeat biopsy.
Grade and stage: what your liver biopsy report measures
When a liver biopsy is done for liver disease, the report often gives two numbers. These describe how active the disease is now, and how much lasting damage it has caused.
- Grado. The grade describes how much active inflammation and liver cell injury is present. A higher grade means more active disease. Inflammation can often improve with treatment.
- Etapa. The stage describes how much scarring, or fibrosis, has built up over time. Scarring develops slowly, and it can sometimes improve when the cause is treated.
Several scoring systems are used, and your report will usually name one. Most use a stage from 0 to 4:
- Etapa 0. Sin cicatrices.
- Etapa 1. Mild scarring limited to the areas around the portal tracts.
- Etapa 2. Scarring has started to extend out from the portal tracts.
- Etapa 3. Bands of scar tissue, called bridging fibrosis, connect different areas of the liver.
- Etapa 4. Scarring has divided the liver into nodules. This is called cirrosis.
Reports may use the Batts-Ludwig system, or the METAVIR system, which assigns stages from F0 to F4. The Ishak system uses stages 0 to 6, where 5 and 6 mean cirrhosis. For fatty liver disease, reports may also give an activity score from 0 to 8, which adds up the fat, inflammation, and liver cell injury seen in the sample.
Common results when a liver biopsy is done for liver disease
A liver biopsy done to investigate liver disease can show many different results. Your report may describe one main finding, or several at once. Common results include:
- Normal liver or minimal changes. The liver looks normal or nearly normal. This can still be useful, because it rules out many conditions.
- Esteatosis. Fat has built up inside the liver cells. Doctors now call fatty liver disease linked to weight, diabetes, or high blood pressure metabolic dysfunction-associated steatotic liver disease (MASLD). This replaces the older name, nonalcoholic fatty liver disease (NAFLD).
- Esteatohepatitis. Fat is present together with inflammation and injured, swollen liver cells. The newer name for the metabolic form is MASH, which replaces NASH. Alcohol can cause the same pattern.
- Hepatitis crónica. Long-lasting inflammation of the liver, most often caused by the hepatitis B or C virus. Blood tests for la hepatitis B y hepatitis C confirm the cause.
- Hepatitis autoinmune. The immune system attacks the liver cells.
- Colangitis biliar primaria (CBP) y colangitis esclerosante primaria (PSC). The immune system damages the bile ducts.
- Drug-induced liver injury. A medicine, supplement, or herbal product has damaged the liver. The biopsy pattern can point to this cause, and your doctor will compare it with what you have been taking.
- Sobrecarga de hierro. The iron stain shows extra iron in the liver. This can be inherited, as in hemochromatosis, or caused by other conditions. Our guide to understanding your iron panel explains the related blood tests.
- Alpha-1 antitrypsin deficiency or Wilson disease. These inherited conditions are suggested by the PAS-D or copper stain and confirmed with blood or genetic tests.
- Colestasis. Bile is backed up in the liver. This is a finding rather than a diagnosis, and it can have many causes.
- granulomas. Small clusters of immune cells are present. Causes include infections, some medicines, and conditions such as sarcoidosis.
- Rechazo. In a transplanted liver, the immune system is attacking the new liver. The report may describe how severe the rejection is.
Common results when a liver biopsy is taken from a spot or lump
A liver biopsy taken from a spot or lump seen on a scan usually answers one question: what is the growth? The main possible results are:
- A noncancerous growth. Los ejemplos incluyen hiperplasia nodular focal, adenoma hepatocelular, adenoma del conducto biliar, hamartoma de las vías biliares, y hemangioma.
- A cancer that started in the liver. El tipo más común es carcinoma hepatocelular, which starts in the liver cells. Colangiocarcinoma intrahepático starts in the bile ducts inside the liver. Rarer types include hepatoblastoma, which occurs in young children, and hemangioendotelioma epitelioide.
- A cancer that spreads to the liver. Cancer that started in another organ and spread to the liver is called a metastásica. This is far more common than cancer that starts in the liver. Common starting points include the colon, pancreas, lung, and breast. Your report may say carcinoma metastásico and use special stains to suggest where it began.
- No growth in the sample. Sometimes the needle samples the liver next to the spot rather than the spot itself. The report will then describe the normal or background liver, and your doctor may suggest another biopsy or a scan.
What happens after a liver biopsy?
What happens after a liver biopsy depends on the result and on the question the biopsy was meant to answer. Your doctor will combine the pathology report with your blood tests, scans, and medical history. The pathologist’s report often ends with a comment explaining how the findings fit with the information provided.
For liver disease, the grade and stage help your care team decide whether you need treatment and how closely to monitor you. For a spot or lump, the diagnosis decides the next step. A noncancerous growth may need no treatment. A cancer leads to further tests and planning with a cancer team. If the sample was too small or missed the spot, a repeat biopsy may be considered.
Preguntas para hacerle a su médico
- Why was my liver biopsy done, and did it answer that question?
- What is the main diagnosis on my liver biopsy report?
- What are the grade and stage of my liver disease?
- Which scoring system did the pathologist use?
- Do I have cirrhosis?
- Was the sample large enough to be reliable?
- Which special stains were done, and what did they show?
- Could any of my medicines or supplements be affecting my liver?
- Do I need more blood tests or genetic tests to confirm the cause?
- If the biopsy was taken from a spot, was the spot itself sampled?
- Is the growth noncancerous, a cancer that started in the liver, or a cancer that spread there?
- ¿Necesitaré otra biopsia en el futuro?
Artículos relacionados en MyPathologyReport.com